Patents by Inventor Mohamad Fadhli Bin MASRI

Mohamad Fadhli Bin MASRI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of serotonergic drugs to treat virus-induced thrombocytopenia
    Patent number: 11426408
    Abstract: The present invention relates to the use of serotonergic compounds for the treatment of virus-induced thrombocytopenia. More particularly, the invention relates to methods of treating thrombocytopenia by blocking serotonin activity. For example, inhibitors of receptor 5HT2A and/or receptor 5HT1A and/or inhibitors of mast cell degranulation and/or inhibitors of serotonin uptake may be used. Preferably, the thrombocytopenia is induced by dengue or Japanese Encephalitis virus, and the inhibitors are preferably ketanserin, WAY-100135, sarpogrelate, or fluoxetine.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: August 30, 2022
    Assignee: NATIONAL UNIVERSITY OF SINGAPORE
    Inventors: Ashley Lauren St. John, Mohamad Fadhli Bin Masri, Abhay Rathore
  • USE OF SEROTONERGIC DRUGS TO TREAT VIRUS-INDUCED THROMBOCYTOPENIA
    Publication number: 20200352947
    Abstract: The present invention relates to the use of serotonergic compounds for the treatment of virus-induced thrombocytopenia. More particularly, the invention relates to methods of treating thrombocytopenia by blocking serotonin activity. For example, inhibitors of receptor 5HT2A and/or receptor 5HT1A and/or inhibitors of mast cell degranulation and/or inhibitors of serotonin uptake may be used. Preferably, the thrombocytopenia is induced by dengue or Japanese Encephalitis virus, and the inhibitors are preferably ketanserin, WAY-100135, sarpogrelate, or fluoxetine.
    Type: Application
    Filed: October 31, 2018
    Publication date: November 12, 2020
    Inventors: Ashley Lauren ST. JOHN, Mohamad Fadhli Bin MASRI, Abhay RATHORE